Effect of Local Intraoperative Steroid on Dysphagia After ACDF
Dysphagia
About this trial
This is an interventional prevention trial for Dysphagia focused on measuring Anterior cervical discectomy and fusion, prevertebral swelling, swallowing, methylprednisolone, intraoperative steroid
Eligibility Criteria
Inclusion Criteria:
Patients undergoing a primary 1- to 3-level ACDF:
(a) Diagnosis: myelopathy, radiculopathy, myeloradiculopathy, stenosis, herniated nucleus pulposus, degenerative disc disease, spondylosis, osteophytic complexes, and foraminal stenosis
- Patients able to provide informed consent
Exclusion Criteria:
Allergies or other contraindications to medicines in the protocol including:
(a) Existing history gastrointestinal bleeding
- Existing history of dysphagia
- Current Smokers
- Cervical spine trauma
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Active Comparator
Placebo Comparator
Local Depomedrol plus IV dexamethasone
IV dexamethasone
Local intraoperative application of methylprednisolone (Depomedrol) plus standard systemic (IV) dexamethasone
Intraoperative systemic (IV) steroid (dexamethasone) only.